Coexistent respiratory allergy and cystic fibrosis.
D000293:Adolescent; D000328:Adult; D000402:Airway Obstruction / Q000188:drug therapy; D001249:Asthma / Q000209:etiology; D002140:California; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000150:complications* / Q000276:immunology; D004804:Eosinophils; D004837:Epinephrine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D005779:Immunodiffusion; D007070:Immunoglobulin A / Q000032:analysis; D007073:Immunoglobulin E / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007545:Isoproterenol / Q000627:therapeutic use; D007958:Leukocyte Count; D008297:Male; D009298:Nasal Polyps / Q000209:etiology; D011863:Radioimmunoassay; D012130:Respiratory Hypersensitivity / Q000150:complications* / Q000453:epidemiology / Q000276:immunology; D006255:Rhinitis, Allergic, Seasonal / Q000209:etiology
D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007073:Immunoglobulin E; D007545:Isoproterenol; D004837:Epinephrine